MedTrace Logo

Arrhythmia Cohort Study

NCT07123896 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-08-14

No results posted yet for this study

Summary

The goal of this prospective, observational registry study is to evaluate the long-term effectiveness, safety, and impact of different kinds of treatment on the quality of life across diverse arrhythmia subtypes and patient populations in hospitalized adults with cardiac arrhythmias (including atrial fibrillation, atrial flutter, supraventricular tachycardia, and ventricular arrhythmias) undergoing routine clinical care.

Conditions

Interventions

DEVICE

Normal treatment with catheter ablation or medicine

Routine clinical care with catheter ablation and/or medicine; real-world clinical cases

DRUG

Drug Treatment

Routine clinical care with medicine; real-world clinical cases

Sponsors & Collaborators

  • Beijing Anzhen Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-24
Primary Completion
2030-07-24
Completion
2030-07-24
FDA Drug
Yes
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07123896 on ClinicalTrials.gov